Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Therapeutic Drug Monitoring
|
January 13, 2006
The DDAH-ADMA-NOS pathway
James M Leiper
Nature Genetics
|
March 30, 2012
The role of ATM in response to metformin treatment and activation of AMPK
Angela Woods, James M Leiper, David Carling
Atherosclerosis. Supplements
|
December 11, 2003
The DDAH/ADMA/NOS pathway
Cam T L Tran, James M Leiper, Patrick Vallance
Circulation
|
March 5, 2003
Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia
Francesca I Arrigoni, Patrick Vallance, Sheila G Haworth, et al.
Plos Medicine
|
September 30, 2005
Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA
Caroline L Smith, Shelagh Anthony, Mike Hubank, et al.
Molecular Biology of the Cell
|
October 17, 2008
Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function
Beata Wojciak-Stothard, Belen Torondel, Lan Zhao, et al.
Biochemical and Biophysical Research Communications
|
August 21, 2003
Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype
Caroline L Smith, Graeme M Birdsey, Shelagh Anthony, et al.
Circulation Research
|
April 20, 2002
all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase
Vinod Achan, Cam T L Tran, Francesca Arrigoni, et al.
Journal of Cell Science
|
March 1, 2007
The ADMA/DDAH pathway is a critical regulator of endothelial cell motility
Beata Wojciak-Stothard, Belen Torondel, Lillian Yen Fen Tsang, et al.
The Journal of Pathology
|
May 19, 2011
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas
Jessica Kr Boult, Simon Walker-Samuel, Yann Jamin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Therapeutic Drug Monitoring
|
January 13, 2006
The DDAH-ADMA-NOS pathway
James M Leiper
Nature Genetics
|
March 30, 2012
The role of ATM in response to metformin treatment and activation of AMPK
Angela Woods, James M Leiper, David Carling
Atherosclerosis. Supplements
|
December 11, 2003
The DDAH/ADMA/NOS pathway
Cam T L Tran, James M Leiper, Patrick Vallance
Circulation
|
March 5, 2003
Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia
Francesca I Arrigoni, Patrick Vallance, Sheila G Haworth, et al.
Plos Medicine
|
September 30, 2005
Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA
Caroline L Smith, Shelagh Anthony, Mike Hubank, et al.
Molecular Biology of the Cell
|
October 17, 2008
Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function
Beata Wojciak-Stothard, Belen Torondel, Lan Zhao, et al.
Biochemical and Biophysical Research Communications
|
August 21, 2003
Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype
Caroline L Smith, Graeme M Birdsey, Shelagh Anthony, et al.
Circulation Research
|
April 20, 2002
all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase
Vinod Achan, Cam T L Tran, Francesca Arrigoni, et al.
Journal of Cell Science
|
March 1, 2007
The ADMA/DDAH pathway is a critical regulator of endothelial cell motility
Beata Wojciak-Stothard, Belen Torondel, Lillian Yen Fen Tsang, et al.
The Journal of Pathology
|
May 19, 2011
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas
Jessica Kr Boult, Simon Walker-Samuel, Yann Jamin, et al.
Page
of 2